Satellos Bioscience Inc.
MSLE | NASDAQ
$6.70
-$0.12 (-1.69%)
At close: Oct 30, 2026, 4:00 PM ET
$6.82
+$0.12 (+1.79%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.09K | 19.99K | 5.28K | 3.73M | 166.94K | 892.78K |
Gross Profit | -5.09K | -19.99K | -5.28K | -3.73M | -166.94K | -892.78K |
Operating Income | -26.46M | -19.38M | -11.66M | -8.43M | -6.65M | -2.77M |
Interest Income | 1.36M | 955.27K | 1M | 63K | 6.26K | n/a |
Pretax Income | -24.7M | -19.58M | -11.98M | -11.32M | -15.51M | -1.58M |
Net Income | -24.87M | -19.58M | -11.98M | -11.32M | -15.51M | -1.58M |
Selling & General & Admin | 7.44M | 5.16M | 4.57M | 4.69M | 2.62M | 987.53K |
Research & Development | 18.43M | 13.66M | 6.65M | 3.73M | 2M | 892.78K |
Other Expenses | 595K | 554.63K | 442.49K | -3.73M | n/a | n/a |
Operating Expenses | 26.46M | 19.38M | 11.66M | 4.69M | 4.63M | 1.88M |
Interest Expense | n/a | n/a | 133.42K | n/a | 772.8K | 499 |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 174.47K |
Cost & Expenses | 26.46M | 19.38M | 11.66M | 8.43M | 6.65M | 2.77M |
Income Tax Expense | 172K | n/a | n/a | 5K | n/a | n/a |
Shares Outstanding (Basic) | 1.22M | 9.56M | 7.2M | 2.97M | 2.01M | 1.48M |
Shares Outstanding (Diluted) | 1.22M | 9.56M | 7.2M | 2.97M | 2.01M | 1.48M |
EPS (Basic) | -20.40 | -2.16 | -1.63 | -3.81 | -6.02 | -1.07 |
EPS (Diluted) | -20.40 | -2.16 | -1.63 | -3.81 | -6.02 | -1.07 |
EBITDA | -26.45M | -19.56M | -11.84M | -8.09M | -4.72M | -1.61M |
EBIT | -26.46M | -19.58M | -11.84M | -8.43M | -4.89M | -1.61M |
Depreciation & Amortization | 5K | 13.94K | 5.28K | 337K | 166.94K | 422 |
Add to Watchlist
Select watchlists to add or remove MSLE